Petmed Express Inc(PETS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 4:00 PM ET (Korea 10/28 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.39 | Insider Own | 33.61% | Shs Outstand | 21.7M | Perf Week | -1.67% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | 30% | Insider Trans | 0.34% | Shs Float | 14.4M | Perf Month | -16.01% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.11 | Inst Own | 21.9% | Short Float | 6.23% | Perf Quarter | -40.4% |
| Income | -0.03B | P/S | 0.15 | EPS this Y | 81.75% | Inst Trans | -8.41% | Short Ratio | 8.03 | Perf Half Y | -47.56% |
| Sales | 0.17B | P/B | 1.11 | EPS next 5Y | 49.64% | ROA | -33.73% | Short Interest | 0.90M | Perf YTD | -63.13% |
| Book/sh | 1.06 | P/C | 1.96 | EPS past 3/5Y | - | ROE | -78.56% | 52W High | -71.22% ($4.10) | Perf Year | -55.64% |
| Cash/sh | 0.6 | P/FCF | - | Sales past 3/5Y | -11.31% -10.35% | ROIC | -127.36% | 52W Low | 2.61% ($1.15) | Perf 3Y | -87.39% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.91% | Gross Margin | 22.44% | Volatility(W/M) | 4.91% 3.93% | Perf 5Y | -95.53% |
| Dividend TTM | - | EV/Sales | 0.08 | Sales Y/Y TTM | -19.67% | Oper. Margin | -18.22% | ATR (14) | 0.05 | Perf 10Y | -94.05% |
| Dividend Ex-Date | 2023/8/11 | Quick Ratio | 0.47 | EPS Q/Q | 82.78% | Profit Margin | -17.34% | RSI (14) | 31.08 | Recom | 5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.68 | Sales Q/Q | -19.86% | SMA20 | -5.58% ($1.25) | Beta | 0.82 | Target Price | $1.4 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2026/8/13 | SMA50 | -22.28% ($1.52) | Rel Volume | 0.56 | Prev Close | $1.16 |
| Employees | 189 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -333.33% - | SMA200 | -45.03% ($2.15) | Avg Volume(3M) | 0.11M | Price | $1.18 |
| IPO | 1999/4/26 | Option/Short | Yes/Yes | Trades | 260 | Volume | 62,033 | Change | 1.72% |
🐶 PetMed Express, Inc. (PETS) is a U.S. company that sells prescription medications and supplies for pets online and by phone under the "1-800-PetMeds" brand. Its core products include flea and tick treatments, heartworm preventatives, prescription pet food, and nutritional supplements.
Over the past 1 year, on the lower side
71% below its 1-year high.
Traded less than usual. That is 56% of its average volume.
PETS has weak earnings and a weak balance sheet
Of every $100 in sales, $18.22 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +81.8% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $15. Peers typically go for $277. Compared with its own 2-year average, it is 724% pricier now.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Sell.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -95.5%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 21.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #3 of 5 in the industry
Based on market cap of $26M.
HITI#1 High Tide Inc $239M PER - 
POM#2 Pomdoctor Ltd $38M PER - PETS#3 Petmed Express Inc $26M PER - 
SCNX#4 Scienture Holdings Inc $5M PER - 
RDGT#5 Ridgetech Inc $3M PER - 
FAQ
What kind of company is PETS?
PETS belongs to the Healthcare sector and operates in the Pharmaceutical Retailers industry.
What is the market cap of PETS?
The market cap of PETS is approximately $26M, ranking 5,140 within its sector.
What is the 52-week high and low for PETS?
PETS has recorded a 52-week high of $4.10 and a low of $1.15.
